PFE
Pfizer Inc
Pfizer Inc historical holders
total: 18
Jensen Investment Management Pfizer Inc transactions over time
- Total transactions:
- 40
- New positions:
- 2
- Sold out:
- 2
- Added:
- 21
- Reduced:
- 15
- Held since:
- 2018 Q2
- Held for:
- 23 quarters
- Latest activity:
- 2024 Q1
Eric H. Schoenstein has been an institutional investor in Pfizer Inc (PFE) since at least 2013 Q2. According to 2026 Q1 report, Eric H. Schoenstein doesn't hold any shares. In our earliest available record from 2013 Q2, Jensen Investment Management held 17,775 shares of PFE. Eric H. Schoenstein later completely sold out the position and reinvested in PFE again in 2018 Q2. Since at least 2013 Q2, Jensen Investment Management has made 39 more transactions in this position.
When did Eric H. Schoenstein exit their PFE position?
Eric H. Schoenstein no longer holds Pfizer Inc (PFE). They sold off their entire position in 2024 Q1, closing out an investment that began in 2013 Q2.
Has Eric H. Schoenstein reinvested in PFE after selling?
Yes, Eric H. Schoenstein has shown renewed interest in Pfizer Inc (PFE). After completely selling their position, they reinitiated an investment in 2018 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $39.04
- Weighted AVG sell price:
- $31.88
PFE transactions history by Jensen Investment Management
40 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q1
|
0.00%
|
0
|
$28.79
|
|
-100% (-11,775,507)
|
-2.57%
|
|
2023 Q4
|
2.57%
|
11,775,507
|
$28.79
|
$339,016,847
|
-2.81% (-340,333)
|
-0.08%
|
|
2023 Q3
|
3.18%
|
12,115,840
|
$33.17
|
$401,882,413
|
+3.00% (+353,202)
|
+0.09%
|
|
2023 Q2
|
3.17%
|
11,762,638
|
$36.68
|
$431,453,562
|
+1.25% (+145,243)
|
+0.04%
|
|
2023 Q1
|
3.70%
|
11,617,395
|
$40.38
|
$469,110,410
|
+10.37% (+1,091,421)
|
+0.35%
|
|
2022 Q4
|
4.22%
|
10,525,974
|
$51.24
|
$539,350,908
|
+5.51% (+549,885)
|
+0.22%
|
|
2022 Q3
|
3.80%
|
9,976,089
|
$43.76
|
$436,554,000
|
-0.64% (-64,005)
|
-0.02%
|
|
2022 Q2
|
4.36%
|
10,040,094
|
$52.43
|
$526,402,000
|
+3.42% (+332,121)
|
+0.14%
|
|
2022 Q1
|
3.75%
|
9,707,973
|
$51.77
|
$502,582,000
|
+0.76% (+73,574)
|
+0.03%
|
|
2021 Q4
|
4.00%
|
9,634,399
|
$59.05
|
$568,911,000
|
-9.65% (-1,029,457)
|
-0.48%
|
|
2021 Q3
|
3.63%
|
$43.01
|
-6.39% (-727,361)
|
|||
|
2021 Q2
|
3.37%
|
$39.16
|
-0.71% (-81,970)
|
|||
|
2021 Q1
|
3.33%
|
$36.23
|
+2.22% (+249,576)
|
|||
|
2020 Q4
|
3.42%
|
$36.81
|
+0.49% (+54,808)
|
|||
|
2020 Q3
|
3.63%
|
$36.70
|
+7.32% (+761,980)
|
|||
|
2020 Q2
|
3.26%
|
$32.70
|
+6.74% (+657,083)
|
|||
|
2020 Q1
|
3.56%
|
$32.64
|
+9.84% (+873,732)
|
|||
|
2019 Q4
|
3.45%
|
$39.18
|
+6.16% (+514,725)
|
|||
|
2019 Q3
|
3.21%
|
$35.93
|
+30.34% (+1,946,530)
|
|||
|
2019 Q2
|
3.17%
|
$43.32
|
+24.62% (+1,267,287)
|
|||
|
2019 Q1
|
2.60%
|
$42.47
|
+6.11% (+296,351)
|
|||
|
2018 Q4
|
2.99%
|
$43.65
|
-0.05% (-2,495)
|
|||
|
2018 Q3
|
2.67%
|
$44.07
|
+59.66% (+1,813,610)
|
|||
|
2018 Q2
|
1.48%
|
$36.28
|
new
|
|||
|
2017 Q2
|
0.00%
|
$34.18
|
-100% (-13,634)
|
|||
|
2016 Q4
|
0.01%
|
$32.49
|
-3.20% (-450)
|
|||
|
2016 Q3
|
0.01%
|
$33.87
|
+13.58% (+1,684)
|
|||
|
2016 Q2
|
0.01%
|
$35.24
|
-5.63% (-740)
|
|||
|
2016 Q1
|
0.01%
|
$29.60
|
+9.23% (+1,110)
|
|||
|
2015 Q4
|
0.01%
|
$32.25
|
-9.07% (-1,200)
|
|||
|
2015 Q3
|
0.01%
|
$31.44
|
-11.03% (-1,640)
|
|||
|
2015 Q2
|
0.01%
|
$33.56
|
-8.55% (-1,390)
|
|||
|
2015 Q1
|
0.01%
|
$34.81
|
-5.30% (-910)
|
|||
|
2014 Q4
|
0.01%
|
$31.16
|
-0.12% (-20)
|
|||
|
2014 Q3
|
0.01%
|
$29.55
|
+8.73% (+1,380)
|
|||
|
2014 Q2
|
0.01%
|
$29.66
|
-5.27% (-880)
|
|||
|
2014 Q1
|
0.01%
|
$32.12
|
+4.12% (+660)
|
|||
|
2013 Q4
|
0.01%
|
$30.63
|
+4.29% (+660)
|
|||
|
2013 Q3
|
0.01%
|
$28.69
|
-13.53% (-2,405)
|
|||
|
2013 Q2
|
0.01%
|
$28.02
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.